Intrathoracic Patterns of Failure for Non-Small-Cell Lung Cancer With Positron-Emission Tomography/Computed Tomography-Defined Target Delineation

International Journal of Radiation Oncology Biology Physics

Volumn 69, Issue 5, 2007, Pages 1409-1416

  Klopp, Ann Hoge ^a   Chang, Joe Y ^a   Tucker, Susan L ^a   Sulman, Erik P ^a   Balter, Peter A ^a   Liu, H Helen ^a   Bucci, M Kara ^a   Macapinlac, Homer A ^a   Komaki, Ritsuko ^a   Cox, James D ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Computed tomography; Non small cell lung cancer; Patterns of failure; Positron emission tomography; Radiation therapy; Target delineation

Indexed keywords

COMPUTERIZED TOMOGRAPHY; ONCOLOGY; PATTERN RECOGNITION; POSITRON EMISSION TOMOGRAPHY;

NON-SMALL-CELL LUNG CANCER; PATTERNS OF FAILURE; TARGET DELINEATION;

RADIOTHERAPY;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER RECURRENCE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DOSIMETRY; FEMALE; FOLLOW UP; HUMAN; LUNG NON SMALL CELL CANCER; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECURRENCE RISK; SIMULATION; TREATMENT PLANNING;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 36148946376     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.05.085     Document Type: Article

References (20)

1. Reske S.N., Grillenberger K.G., Glatting G., et al. Overexpression of glucose transporter 1 and increased FDG uptake in pancreatic carcinoma. J Nucl Med 38 (1997) 1344-1348
2. 18F]fluorodeoxyglucose. Part I. Biochemical uptake mechanism and its implication for clinical studies. J Cancer Res Clin Oncol 126 (2000) 549-559
3. Lardinois D., Weder W., Hany T.F., et al. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 348 (2003) 2500-2507
4. Pieterman R.M., van Putten J.W., Meuzelaar J.J., et al. Preoperative staging of non-small-cell lung cancer with positron-emission tomography. N Engl J Med 343 (2000) 254-261
5. Brianzoni E., Rossi G., Ancidei S., et al. Radiotherapy planning: PET/CT scanner performances in the definition of gross tumour volume and clinical target volume. Eur J Nucl Med Mol Imaging 32 (2005) 1392-1399
6. Bradley J., Thorstad W.L., Mutic S., et al. Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 59 (2004) 78-86
7. Steenbakkers R.J., Duppen J.C., Fitton I., et al. Reduction of observer variation using matched CT-PET for lung cancer delineation: A three-dimensional analysis. Int J Radiat Oncol Biol Phys 64 (2006) 435-448
8. Gondi V., Bradley K., Mehta M., et al. Impact of hybrid fluorodeoxyglucose positron emission tomography/computed tomography on radiotherapy planning in esophageal and non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 67 (2007) 187-195
9. Fox J.L., Rengan R., O'Meara W., et al. Does registration of PET and planning CT images decrease interobserver and intraobserver variation in delineating tumor volumes for non-small-cell lung cancer?. Int J Radiat Oncol Biol Phys 62 (2005) 70-75
10. 18FDG-PET CT planning in patients with clinical CT stage N2-N3M0 non-small-cell lung cancer: A modeling study. Int J Radiat Oncol Biol Phys 61 (2005) 649-655
11. Vesselle H., Schmidt R.A., Pugsley J.M., et al. Lung cancer proliferation correlates with [F-18]fluorodeoxyglucose uptake by positron emission tomography. Clin Cancer Res 6 (2000) 3837-3844
12. Clavo A.C., Brown R.S., and Wahl R.L. Fluorodeoxyglucose uptake in human cancer cell lines is increased by hypoxia. J Nucl Med 36 (1995) 1625-1632
13. Downey R.J., Akhurst T., Gonen M., et al. Preoperative F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection. J Clin Oncol 22 (2004) 3255-3260
14. 18F]fluorodeoxyglucose uptake by positron emission tomography predicts outcome of non-small-cell lung cancer. J Clin Oncol 23 (2005) 1136-1143
15. Senan S., Burgers S., Samson M.J., et al. Can elective nodal irradiation be omitted in Stage III non-small-cell lung cancer? Analysis of recurrences in a Phase II study of induction chemotherapy and involved-field radiotherapy. Int J Radiat Oncol Biol Phys 54 (2002) 999-1006
16. Belderbos J.S., De Jaeger K., Heemsbergen W.D., et al. First results of a phase I/II dose escalation trial in non-small cell lung cancer using three-dimensional conformal radiotherapy. Radiother Oncol 66 (2003) 119-126
17. Rosenzweig K.E., Sim S.E., Mychalczak B., et al. Elective nodal irradiation in the treatment of non-small-cell lung cancer with three-dimensional conformal radiation therapy. Int J Radiat Oncol Biol Phys 50 (2001) 681-685
18. Keyes J.W. SUV: Standard uptake or silly useless value?. J Nucl Med 36 (1995) 1836-1839
19. 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute trials. J Nucl Med 47 (2006) 1059-1066
20. Pan T., Mawlawi ONehmeh S.A., et al. Attenuation correction of PET images with respiration-averaged CT images in PET/CT. J Nucl Med 46 (2005) 1481-1487